Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY – Get Free Report) was the target of a large growth in short interest in July. As of July 15th, there was short interest totalling 300 shares, a growth of 50.0% from the June 30th total of 200 shares. Based on an average trading volume of 14,100 shares, the short-interest ratio is currently 0.0 days.
Sinopharm Group Stock Up 0.3 %
Shares of SHTDY traded up $0.04 during mid-day trading on Friday, hitting $11.75. 11,583 shares of the stock were exchanged, compared to its average volume of 12,013. Sinopharm Group has a 52-week low of $11.36 and a 52-week high of $16.31. The firm has a 50-day moving average of $13.19 and a two-hundred day moving average of $13.21.
Sinopharm Group Increases Dividend
The company also recently disclosed a dividend, which will be paid on Wednesday, August 28th. Stockholders of record on Wednesday, June 19th will be issued a dividend of $0.491 per share. This represents a dividend yield of 3.57%. This is a boost from Sinopharm Group’s previous dividend of $0.49. The ex-dividend date of this dividend is Tuesday, June 18th.
Sinopharm Group Company Profile
Sinopharm Group Co Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business.
Read More
- Five stocks we like better than Sinopharm Group
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Call Options Volume for These 2 Stocks Spiked Together
- What Is WallStreetBets and What Stocks Are They Targeting?
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.